Skip to content

Clinical trials

Phase 2 Breast Neoplasms trials in Portugal

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Breast Neoplasms Phase: Phase 2 Country / region: Portugal Clear all

28 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20051
20071
20081
20092
20122
20131
20143
20152
20161
20171
20181
20194
20204
20221
20242

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed18
Active, not recruiting4
Terminated4
Not yet recruiting1
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Hoffmann-La Roche3
MedSIR3
Puma Biotechnology, Inc.3
SOLTI Breast Cancer Research Group3
AstraZeneca2
Genentech, Inc.2
Novartis Pharmaceuticals2
Actuate Therapeutics Inc.1
Bayer1
Boehringer Ingelheim1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Breast Neoplasms28
Neoplasm Metastasis3
Neoplasms3
Bone Neoplasms2
Brain Neoplasms2
Colorectal Neoplasms2
Sarcoma2
Biliary Tract Neoplasms1
Bone Diseases1
Carcinoma, Non-Small-Cell Lung1

Trials

Showing 1 to 25 of 28. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.